Company: EDSA
Filing Date: 2025-03-11
Form Type: 424B3
Source: 0001171843-25-001403
Chunk: 13

Company: Edesa Biotech, Inc.
Filing Date: 2025-03-11
Form: 424B3
Chunk 13
---
 and (iii) increase or decrease the authorized number of Preferred Shares, in each case, without the written consent
of the Lead Investors.

| 11 |

### PLAN OF DISTRIBUTION
The Selling Shareholders, which as used
herein includes donees, pledgees, transferees or other successors-in-interest selling Shares previously issued and the Conversion Shares
issuable upon conversion of the Preferred Shares or interests in the Shares or the Conversion Shares received after the date of this prospectus
from a Selling Shareholder as a gift, pledge, partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise
dispose of any or all of their Shares or Conversion Shares or interests in the Shares or the Conversion Shares on any stock exchange,
market or trading facility on which the shares are traded or in private transactions. The Selling Shareholders may sell their Shares or
Conversion Shares pursuant to this prospectus at fixed prices, at prevailing market prices at the time of sale, at prices related to the
prevailing market price, at varying prices determined at the time of sale, or at negotiated prices.

The Selling Shareholders may use any one or more of the following methods when disposing
of the Shares, Conversion Shares, or interests therein:

| · | ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; |

| · | block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and 
 resell a portion of the block as principal to facilitate the transaction;                              |

| · | purchases by a broker-dealer as principal and resale by the broker-dealer for its account; |

| · | an exchange distribution in accordance with the rules of the applicable exchange; |

| · | privately negotiated transactions; |

| · | short sales; |

| · | through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; |

| · | broker-dealers may agree with the Selling Shareholders to sell a specified number of such shares at a stipulated price per share; |

| · | a combination of any such methods of sale; and |

| · | any other method permitted pursuant to applicable law. |

The Selling Shareholders may, from time
to time, pledge or grant a security interest in some or all of the Shares or Preferred Shares owned by them and, if they default in the
performance of their secured obligations, the pledgees or secured parties may offer and sell the Shares or Conversion Shares,